Innate Pharma S.A.
IPH.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€49 | -€8 | -€58 | -€53 |
| Dep. & Amort. | €2 | €5 | €45 | €5 |
| Deferred Tax | €0 | €0 | €0 | -€2 |
| Stock-Based Comp. | €0 | €4 | €4 | €3 |
| Change in WC | €39 | -€32 | -€13 | -€10 |
| Other Non-Cash | €1 | -€2 | €2 | -€1 |
| Operating Cash Flow | -€7 | -€33 | -€19 | -€58 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€0 | -€2 | -€1 | -€1 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €10 | €23 | €3 | €0 |
| Other Inv. Act. | €0 | €0 | -€0 | €0 |
| Investing Cash Flow | €9 | €21 | €2 | -€1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€9 | -€2 | -€2 | €27 |
| Stock Issued | €3 | €0 | €0 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €0 | €0 | €0 | -€0 |
| Financing Cash Flow | -€6 | -€2 | -€2 | €27 |
| Forex Effect | -€1 | €0 | -€0 | -€0 |
| Net Chg. in Cash | -€4 | -€14 | -€20 | -€33 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €71 | €84 | €104 | €137 |
| End Cash | €66 | €71 | €84 | €104 |
| Free Cash Flow | -€7 | -€35 | -€20 | -€60 |